We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ACARIX.ST

Price
0.26
Stock movement up
+0.01 (1.92%)
Company name
Acarix A/S
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Medical Devices
Market cap
281.89M
Ent value
247.20M
Price/Sales
49.65
Price/Book
4.40
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-29.00%
1 year return
-19.21%
3 year return
-31.91%
5 year return
-16.58%
10 year return
-
Last updated: 2025-06-22

DIVIDENDS

ACARIX.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales49.65
Price to Book4.40
EV to Sales43.54

FINANCIALS

Per share

Loading...
Per share data
Current share count1.06B
EPS (TTM)-0.07
FCF per share (TTM)-0.07

Income statement

Loading...
Income statement data
Revenue (TTM)5.68M
Gross profit (TTM)5.13M
Operating income (TTM)-72.06M
Net income (TTM)-72.23M
EPS (TTM)-0.07
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)90.31%
Operating margin (TTM)-1269.28%
Profit margin (TTM)-1272.31%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash44.18M
Net receivables3.40M
Total current assets62.79M
Goodwill0.00
Intangible assets10.25M
Property, plant and equipment510.00K
Total assets73.55M
Accounts payable5.12M
Short/Current long term debt0.00
Total current liabilities9.49M
Total liabilities9.49M
Shareholder's equity64.06M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-69.49M
Capital expenditures (TTM)741.00K
Free cash flow (TTM)-70.23M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-112.75%
Return on Assets-98.20%
Return on Invested Capital-112.75%
Cash Return on Invested Capital-109.63%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.26
Daily high0.28
Daily low0.26
Daily Volume844K
All-time high8.29
1y analyst estimate0.45
Beta1.48
EPS (TTM)-0.07
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ACARIX.STS&P500
Current price drop from All-time high-96.86%-2.53%
Highest price drop-97.86%-56.47%
Date of highest drop21 Dec 20239 Mar 2009
Avg drop from high-79.93%-11.04%
Avg time to new high428 days12 days
Max time to new high2135 days1805 days
COMPANY DETAILS
ACARIX.ST (Acarix A/S) company logo
Marketcap
281.89M
Marketcap category
Small-cap
Description
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Employees
14
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Acarix, a leader in non-invasive cardiac diagnostics, is pleased to announce the publication of a new peer-reviewed study in PharmacoEconomics – Open demonstrating that the CADScor® System is a cost-e...
June 26, 2025
Acarix, a global leader in AI and acoustics-based cardiac diagnostics, has been awarded the 2025 Digital Innovation Award with an honorable mention for Innovation in Cardiac Imaging at the Global Card...
March 14, 2025
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial results. "The company continues to demonstrate exceptional progress in its pursuit of o...
February 13, 2025
Acarix, a pioneer in the development of groundbreaking acoustic-based cardiac diagnostic solutions, is proud to announce a new strategic partnership with Geo-Med, LLC, a renowned Service-Disabled Vete...
February 5, 2025
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has decided that the CPT code 0716T - the CADScor® Sy...
November 4, 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 2024. The company achieved record-breaking patch sales and record-b...
August 22, 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces expanded use of the CADScor System within wellness exams as part of self-insured companies' health plans. As healthcare ...
August 12, 2024
VANCOUVER, BC / ACCESSWIRE / July 30, 2024 / Acarix CEO Aamir Mahmood joined Steve Darling from Proactive to share news the company has begun trading on the OTCQB Market in the United States, under th...
July 30, 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that the Acarix shares (OTCQB: ACIXF) begin trading today on the OTCQB Market in the US. Acarix´s shares wi...
July 15, 2024